$PFE

Long

Pfizer · Core coverage · Healthcare

Technical snapshot

as of Oct 6, 2026
Price27.50
RSI (14)43.60Neutral
MACD0.10Below signal

Chart

PFE price chart with 50- and 200-day moving averages

Daily close with 50/200-day SMA and volume · Oct 6, 2026

The 50-SMA has crossed above the 200-SMA and price is holding both, keeping the longer-term structure constructive. RSI at 43.61 is in neutral-but-soft territory, signaling the pullback is mature rather than overextended, while MACD at 0.10 under its 0.23 signal line confirms near-term momentum is still fading. The 27.44 50-SMA is the pivot: reclaiming it decisively reasserts the uptrend, while losing it opens air back toward the 200-SMA at 26.42.

Playbook history

PFE — frequently asked

Is PFE above its 200-day moving average?
Yes — Pfizer ($PFE) is trading 4.10% above its 200-day moving average (around 26.42), which reflects a long-term uptrend. (Educational only, not financial advice.)
Is PFE overbought or oversold?
PFE's 14-day RSI is 44, which is neutral. RSI above 70 is overbought, below 30 is oversold, and in between is neutral. (Educational only, not financial advice.)
What is PFE's RSI?
PFE's current 14-day RSI is 44 (neutral). (Educational only, not financial advice.)
Is PFE in an uptrend or a downtrend?
PFE's 50-day moving average (27.44) is above its 200-day (26.42), a bullish (golden-cross) structure. (Educational only, not financial advice.)
What is the latest read on PFE?
Our most recent Daily Playbook reads PFE as Long (#5 · Long · 27.50). (Educational only, not financial advice.)

Get PFE signals the moment they fire

Daily Playbook reads, real-time technical alerts, and human-vetted AI analysis across the market's leaders.

Educational only. Not financial advice. Technicals are end-of-day and may lag live prices.